Wayne Macfadden

3.2k total citations · 1 hit paper
43 papers, 2.2k citations indexed

About

Wayne Macfadden is a scholar working on Psychiatry and Mental health, Ophthalmology and Pharmacology. According to data from OpenAlex, Wayne Macfadden has authored 43 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 10 papers in Ophthalmology and 8 papers in Pharmacology. Recurrent topics in Wayne Macfadden's work include Bipolar Disorder and Treatment (18 papers), Schizophrenia research and treatment (16 papers) and Electroconvulsive Therapy Studies (11 papers). Wayne Macfadden is often cited by papers focused on Bipolar Disorder and Treatment (18 papers), Schizophrenia research and treatment (16 papers) and Electroconvulsive Therapy Studies (11 papers). Wayne Macfadden collaborates with scholars based in United States, Switzerland and United Kingdom. Wayne Macfadden's co-authors include Richard H. Weisler, Joseph R. Calabrese, Terence A. Ketter, Paul E. Keck, Björn Paulsson, Arifulla Khan, Michael E. Thase, William Chang, Margaret Minkwitz and Robin McCoy and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Wayne Macfadden

42 papers receiving 2.1k citations

Hit Papers

A Randomized, Double-Blind, Placebo-Controlled Trial of Q... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression
    2005 587 citations Joseph R. Calabrese, Paul E. Keck et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wayne Macfadden United States 20 1.5k 488 362 331 188 43 2.2k
Raymund Schwan France 22 430 0.3× 213 0.4× 124 0.3× 65 0.2× 198 1.1× 134 1.5k
Bernhard J. Connemann Germany 21 444 0.3× 137 0.3× 86 0.2× 118 0.4× 204 1.1× 116 1.4k
Christoph Born Germany 24 511 0.3× 131 0.3× 85 0.2× 82 0.2× 190 1.0× 49 1.2k
Lea T. Drye United States 24 940 0.6× 415 0.9× 283 0.8× 21 0.1× 164 0.9× 46 1.9k
Jill Gonzales United States 14 412 0.3× 251 0.5× 87 0.2× 72 0.2× 190 1.0× 17 824
Alain Robillard Canada 14 536 0.3× 190 0.4× 121 0.3× 122 0.4× 38 0.2× 18 1.4k
R J Wyatt United States 14 777 0.5× 98 0.2× 16 0.0× 76 0.2× 290 1.5× 21 1.5k
Po‐Han Chou Taiwan 19 225 0.1× 62 0.1× 25 0.1× 157 0.5× 130 0.7× 70 1.1k
Ingo Kilimann Germany 24 681 0.4× 76 0.2× 11 0.0× 129 0.4× 120 0.6× 58 1.4k
Ladislav Hosák Czechia 15 310 0.2× 63 0.1× 26 0.1× 27 0.1× 113 0.6× 57 807

Countries citing papers authored by Wayne Macfadden

Since Specialization
Citations

This map shows the geographic impact of Wayne Macfadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Macfadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Macfadden more than expected).

Fields of papers citing papers by Wayne Macfadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Macfadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Macfadden. The network helps show where Wayne Macfadden may publish in the future.

Co-authorship network of co-authors of Wayne Macfadden

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Macfadden. A scholar is included among the top collaborators of Wayne Macfadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Macfadden. Wayne Macfadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ben‐Joseph, Rami, Virend K. Somers, Jed Black, et al.. (2024). Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study. Mayo Clinic Proceedings. 99(11). 1710–1721. 5 indexed citations
2.
Schneider, Logan, et al.. (2023). Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE). Nature and Science of Sleep. Volume 15. 89–101. 13 indexed citations
3.
Schneider, Logan, et al.. (2023). Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE). Nature and Science of Sleep. Volume 15. 593–606. 14 indexed citations
4.
Koh, Adrian, Timothy Y. Y. Lai, Wen Bin Wei, et al.. (2019). REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY. Retina. 40(8). 1529–1539. 10 indexed citations
5.
Pearce, Ian, et al.. (2018). Real-world outcomes of ranibizumab in patients with retinal vein occlusion from the LUMINOUS™ study. Investigative Ophthalmology & Visual Science. 59(9). 2566–2566. 1 indexed citations
6.
Silva, Rufino, András Berta, Michael Larsen, et al.. (2017). Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration. Ophthalmology. 125(1). 57–65. 200 indexed citations
7.
Guymer, Robyn H. & Wayne Macfadden. (2016). Baseline characteristics and 1-year outcomes of patients with neovascular age-related macular degeneration from the real-world LUMINOUS™ study: global results vs Australian cohort. Investigative Ophthalmology & Visual Science. 57(12). 531–531. 1 indexed citations
8.
Calabrese, Joseph R., Maurizio Fava, George Garibaldi, et al.. (2014). Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. Journal of Affective Disorders. 168. 439–451. 49 indexed citations
9.
Macfadden, Wayne, Cherilyn DeSouza, Concetta Crivera, et al.. (2011). Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results. BMC Psychiatry. 11(1). 167–167. 27 indexed citations
10.
11.
Bagalman, Erin, Erik Muser, Jiyoon Choi, et al.. (2011). Health Care Resource Utilization and Costs in a Commercially Insured Population of Patients With Bipolar Disorder Type I and Frequent Psychiatric Interventions. Clinical Therapeutics. 33(10). 1381–1390.e4. 12 indexed citations
12.
Veach, Jeffrey, et al.. (2010). Assessment of Clinician Awareness of Nonadherence Using a New Structured Rating Scale. Journal of Psychiatric Practice. 16(3). 164–169. 13 indexed citations
13.
Haskins, J. Thomas, Wayne Macfadden, Norris Turner, et al.. (2010). Clinical characteristics and resource utilization of patients with bipolar disorder who have frequent psychiatric interventions. Journal of Medical Economics. 13(3). 552–558. 5 indexed citations
14.
Macfadden, Wayne, Cynthia A. Bossie, Ibrahim Turkoz, & J. Thomas Haskins. (2010). Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia. International Clinical Psychopharmacology. 25(2). 75–82. 18 indexed citations
15.
Durden, Emily, Erin Bagalman, Erik Muser, et al.. (2010). Characteristics, healthcare utilization and costs of bipolar disorder type I patients with and without frequent psychiatric intervention in a Medicaid population. Journal of Medical Economics. 13(4). 698–704. 9 indexed citations
16.
17.
18.
Thase, Michael E., Wayne Macfadden, Richard H. Weisler, et al.. (2006). Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression. Journal of Clinical Psychopharmacology. 26(6). 600–609. 399 indexed citations
19.
Calabrese, Joseph R., Paul E. Keck, Wayne Macfadden, et al.. (2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression. American Journal of Psychiatry. 162(7). 1351–1360. 587 indexed citations breakdown →
20.
Bakke, John L., et al.. (1961). THE FRACTIONATION OF EXOGENOUS AND ENDOGENOUS THYROID-STIMULATING HORMONE FROM HUMAN AND RAT PLASMA AND TISSUES*. The Journal of Clinical Endocrinology & Metabolism. 21(10). 1280–1289. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymund Schwan Breakdown of academic impact, for papers by Bernhard J. Connemann Breakdown of academic impact, for papers by Christoph Born Breakdown of academic impact, for papers by Lea T. Drye Breakdown of academic impact, for papers by Jill Gonzales Breakdown of academic impact, for papers by Alain Robillard Breakdown of academic impact, for papers by R J Wyatt Breakdown of academic impact, for papers by Po‐Han Chou Breakdown of academic impact, for papers by Ingo Kilimann Breakdown of academic impact, for papers by Ladislav Hosák
Rankless by CCL
2026